Results 21 to 30 of about 21,198 (196)
Journal for ImmunoTherapy of Cancer, 2022 Background The complete response rate of cervical high-grade squamous intraepithelial lesion (cHSIL) patients to imiquimod immunotherapy is approximately 60%. Consequently, many patients are exposed to unnecessary adverse effects of imiquimod.
Natasja Hendriks +12 more
doaj +1 more source
, 2023 IntroductionTranscutaneous immunization (TCI) is a non-invasive vaccination method promoting strong cellular immune responses, crucial for the immunological rejection of cancer.
Sophie Luise Meiser (16917870) +25 more
core +1 more source
Imiquimod-induced hypertrophic lupus erythematosus-like reaction. [PDF]
, 2022 Imiquimod is a topical immunomodulator that acts as an inducer of interferon (IFN)-a expression through Toll-like receptor (TLR)7 signaling with indications for the treatment of non-hyperkeratotic actinic keratosis of the face or scalp, superficial basal
Safadi, Mohannad G +4 more
core +1 more source
Management of superficial basal cell carcinoma: focus on imiquimod
, 2009 Superficial basal cell carcinoma comprise up to 25% of all histological sub-types. They are more likely to occur on younger persons and females and although generally more common on the trunk, also occur frequently on the exposed areas of the head and ...
Raasch, Beverley, Beverly Raasch
core +2 more sources
Imiquimod induced vitiligo‐like lesions—A consequence of modified melanocyte function
Immunity, Inflammation and Disease, 2022 Introduction Imiquimod plays an important role in the management of condyloma and premalignant lesions. Successively, an increase of hypopigmented lesions following imiquimod application has been reported.
Haiyan Yu +4 more
doaj +1 more source
Systemic adverse events in imiquimod use for cervical intraepithelial neoplasia – A case series
Case Reports in Women's Health, 2019 Treatment for cervical intraepithelial neoplasia (CIN) often consists of an excisional procedure. However, less invasive treatment methods have been explored, such as topical treatment with imiquimod cream.
Tirza Wouters +8 more
doaj +1 more source
The Immunomodulatory Small Molecule Imiquimod Induces Apoptosis in Devil Facial Tumour Cell Lines. [PDF]
PLoS ONE, 2016 The survival of the Tasmanian devil (Sarcophilus harrisii) is threatened by devil facial tumour disease (DFTD). This transmissible cancer is usually fatal, and no successful treatments have been developed.
Amanda L Patchett +4 more
doaj +1 more source
Imiquimod cream improves photodamaged skin
Journal of Dermatology and Dermatologic Surgery, 2022 Chronic exposure to ultraviolet light causes wrinkles and dyspigmentation. Imiquimod cream is an immune-modulator medication approved for the treatment of genital warts, actinic keratosis, and superficial basal cell carcinoma.
Suliman S Alfaraj +2 more
doaj +1 more source
Biology, 2021 The Toll-like receptor (TLR) 7 is a viral sensor for detecting single-stranded ribonucleic acid (ssRNA), the activation of which can induce intracellular innate immunity against viral infections.
Feng-Zhen Meng +6 more
doaj +1 more source
Al-Mustansiriyah Journal of Pharmaceutical Sciences, 2019 The assessment of drug permeation into/across the skin is traditionally accomplished using Franz diffusion cells with subsequent analysis by conventional chromatographic methods such as HPLC and more recently using advanced imaging techniques.
Mohammed Hussain Al-Mayahy +2 more
doaj +1 more source